课题基金 / 基金详情

项目摘要

项目成果

DANIEL H GESCHWIND的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):响应RFA-OD-09-005,恢复法案限制竞争:生物医学研究核心中心,以加强研究资源(P30),这个新应用程序的目的是支持我们的招聘,并提供一个适当的启动包为杰出的临床科学家作为终身职位-跟踪加州大学洛杉矶分校的教师,并开发资源,以支持一个专门的新的生物医学研究核心中心的背景下的研究项目。拟议的核心活动将主要在以下背景下进行:1)加州大学洛杉矶分校自闭症研究和治疗中心(CART),这是六个NIH自闭症卓越中心(ACE)之一,也是五个ACE网络赠款之一(PI,Geschwind);并将涉及在2)神经行为遗传学中心(CNG),拥有国际公认的神经遗传学项目这两个中心都是在塞梅尔神经科学和人类行为研究所(塞梅尔研究所;前身为神经精神研究所)内开发的,该研究所为与心理健康相关的广泛临床和基础研究活动提供支持和凝聚力。最后,在大脑研究所(BRI)和加州大学洛杉矶分校医学中心的监督下,该中心得到了大型高度协作的加州大学洛杉矶分校神经科学界的广泛支持。作为自闭症研究的领先中心,我们采取了多学科的方法来研究自闭症谱系障碍(ASD),在许多层面上整合我们的工作,从早期诊断,遗传学和脑成像到认知,行为,精神药理学和其他治疗方式。特别是与这个拟议的核心中心申请相关的是,CART调查人员在我们的年度务虚会期间参与了战略规划。几年前,这一过程的一个主要成果是明确认识到需要扩大我们的婴儿研究能力,并制定一个电生理学计划。因此,我们目前的最高优先事项,以及该中心申请的计划目标是扩大我们的早期婴儿研究,并增加电生理方法的专业知识,用于研究婴儿和年幼的、语言能力最低的儿童。这一点尤其重要,因为可量化的电生理大脑表型可以帮助我们了解自闭症的一些神经生物学和异质性,特别是与仔细的深层表型,遗传学和神经影像学相结合。 公共卫生相关性:有一个明确认识到需要扩大婴儿的研究能力,并制定一项计划,在电生理学,这是该中心申请的纲领性目标。我们希望扩大我们的早期婴儿研究,并增加电生理学方法的专业知识,用于研究婴儿和年幼的、语言最少的儿童。这一点尤其重要,因为可量化的电生理大脑表型可以帮助我们了解自闭症的一些神经生物学和异质性,特别是与仔细的深层表型,遗传学和神经影像学相结合。
英文摘要
DESCRIPTION (provided by applicant): In response to the RFA-OD-09-005, Recovery Act Limited Competition: Biomedical Research Core Centers to Enhance Research Resources (P30), the aims of this new application are to support our hiring and providing an appropriate start-up package for an outstanding clinician scientist as a tenure-track faculty at UCLA and to develop resources to support research projects within the context of a specialized new biomedical research core center. The proposed core activities will be conducted primarily within the context of: 1) the UCLA Center for Autism Research and Treatment (CART), which is one of six NIH Autism Centers of Excellence (ACE) and also one of five ACE Network grants (PI, Geschwind); and will involve a joint appointment for the successful candidate within 2) the Center for Neurobehavioral Genetics (CNG), housing an internationally recognized program in neurogenetics. Both of these centers have been developed within the Semel Institute for Neuroscience and Human Behavior (Semel Institute; formerly the Neuropsychiatric Institute), which provides support and cohesion for a wide range of clinical and basic research activities related to mental health. Lastly, there is broad support for this center across the large, highly collaborative UCLA neuroscience community overseen by the Brain Research Institute (BRI) and the UCLA medical center. As a leading center for autism research, we have taken a multidisciplinary approach to the study of autism spectrum disorders (ASD), integrating our work at many levels, from early diagnosis, genetics and brain imaging to cognition, behavior, psychopharmacology and other treatment modalities. Of particular relevance to this proposed core center application, CART investigators have engaged in strategic planning during the course of our annual retreats. Several years ago, a major outcome of this process was the clearly recognized need to expand our infant research capabilities and to develop a program in electrophysiology. Thus, our highest current priority, and the programmatic goal of this center application is to expand our early infant research and to add expertise in electrophysiologic methods for the study of infants and young, minimally verbal children. This is especially important, given that quantifiable, electrophysiologic brain phenotypes may help us understand some of the neurobiology and the heterogeneity in autism, especially in conjunction with careful deep phenotyping, genetics and neuroimaging. PUBLIC HEALTH RELEVANCE: There is a clearly recognized need to expand infant research capabilities and to develop a program in electrophysiology, which is the programmatic goal of this center application. We want to expand our early infant research and add expertise in electrophysiologic methods for the study of infants and young, minimally verbal children. This is especially important, given that quantifiable, electrophysiologic brain phenotypes may help us understand some of the neurobiology and the heterogeneity in autism, especially in conjunction with careful deep phenotyping, genetics and neuroimaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
UCLA High-Throughput Neuropsychiatric Disorder Phenotyping Center (UCLA HT-NPC)
Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: